| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
CLINICAL CASE SEMINAR |
Pediatric Endocrinology Division (A.B., S.T.) and Pediatric Neurology Division (S.P.), Infants and Childrens Hospital of Brooklyn at Maimonides, Brooklyn, New York 11219; Division of Endocrinology, Metabolism, and Molecular Medicine (W.-X.G., J.L.J.), Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611; Pediatric Endocrinology Division (H.A.), Saint Barnabas Medical Center, Livingston, New Jersey 07039; and Department of Radiology (L.H.), Weill Medical College of Cornell University, New York, New York 10021
Address all correspondence and requests for reprints to: Dr. Svetlana Ten, Pediatric Endocrinology Division, Infants and Childrens Hospital of Brooklyn at Maimonides, 977 48th Street, Brooklyn, New York 11219. E-mail: tenlana{at}aol.com.
Context: Mutations in the gene encoding steroidogenic acute regulatory protein (StAR) are the most common cause of lipoid congenital adrenal hyperplasia (lipoid CAH), a disorder characterized by adrenal insufficiency and deficient gonadal steroid synthesis, resulting in female external genitalia in both genetic sexes.
Objective: We describe three new cases of lipoid CAH caused by novel mutations in the StAR gene.
Patients: An XY subject of Yemeni descent presented with adrenal insufficiency and severe undervirilization. Magnetic resonance imaging (MRI) of the brain showed enlarged subarachnoid spaces consistent with frontal and temporal atrophy. Two XX siblings of Palestinian descent presented with neonatal adrenal insufficiency. One had a borderline intelligence quotient and features of attention deficit hyperactivity disorder. MRI showed areas of supratentorial white matter lesions. In her sister, MRI revealed a Chiari-I malformation.
Results: The XY subject was found to have a missense mutation (R182C). Both XX siblings had a dinucleotide deletion at nucleotides 327328 that induces a frame shift that truncates the StAR protein after 68 amino acids.
Conclusions: These cases broaden the spectrum of known StAR mutations and suggest that disorders of central nervous system development may arise because of StAR deficiency and/or the metabolic consequences of neonatal adrenal deficiency.
This article has been cited by other articles:
![]() |
M. Abdulhadi-Atwan, A. Jean, W. K. Chung, K. Meir, Z. Ben Neriah, G. Stratigopoulos, S. E. Oberfield, I. Fennoy, H. J. Hirsch, A. Bhangoo, et al. Role of a Founder c.201_202delCT Mutation and New Phenotypic Features of Congenital Lipoid Adrenal Hyperplasia in Palestinians J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4000 - 4008. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Seto-Young, D. Avtanski, M. Strizhevsky, G. Parikh, P. Patel, J. Kaplun, K. Holcomb, Z. Rosenwaks, and L. Poretsky Interactions among Peroxisome Proliferator Activated Receptor-{gamma}, Insulin Signaling Pathways, and Steroidogenic Acute Regulatory Protein in Human Ovarian Cells J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2232 - 2239. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |